IND Regulatory Services

Boyds’ award-winning regulatory team provides support and guidance throughout the FDA regulatory process for Investigational New Drug (IND) applications, enabling you to meet your IND program’s development timelines and achieve key milestones.

Our regulatory experts can help you with the compilation, submission and lifecycle management of your IND program. Boyds provide a range of services to help you navigate through the complex IND application process, including strategic regulatory support, medical writing, pre-IND meeting, IND publishing and submission and post-IND maintenance.     

To find out more about how Boyds’ award-winning regulatory consultants can support your IND program, get in touch.